MDLZ Mondelez International (MDLZ) Insider Trading, Ownership & Congress Trades
Food & Beverage · Food and kindred products · CIK 0001103982
Congress · 1Form 144 · 1
Insider buyers, 180 days
0
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $6.6M priced
What the filings say about MDLZ
Insiders, 180 days
-$8.6M net sold
2 sellers · 50% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 3 sold
Latest: sale, 2026-08-05
Planned sales (Form 144), 90 days
$8.4M
1 notice
Mondelez International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Mondelez International, Inc. insiders sold a net $8.6M of stock across 25 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 10.1% of the 1,326,488 shares held after it.
- No other insider sold within 30 days.
Insider activity: Chief Executive Officer Van de Put Dirk sold about $8.6M of MDLZ under a 10b5-1 plan on Aug 19, 2026, the largest insider sale at the company since 2021.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Apr 30, 2026.
- No other insider sold within 30 days.
Insider activity: SVP, CTR & Chief Accoun Off Stevens Brian sold about $62 of MDLZ on May 1, 2026.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 300.0% of the 21 shares held after it.
- No other insider sold within 30 days.
Insider activity: SVP, CTR & Chief Accoun Off Stevens Brian sold about $3.9K of MDLZ on Apr 30, 2026.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 3.0% of the 99,596 shares held after it.
- No other insider sold within 30 days.
Insider activity: EVP and President, NA Valle Gustavo Carlos sold about $186.0K of MDLZ on Feb 13, 2026, the largest insider sale at the company since 2023.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 5, 2022.
- The trade is 10.1% of the 205,081 shares held after it.
- No other insider sold within 30 days.
Insider activity: EVP and President AMEA Brusadelli Maurizio sold about $1.4M of MDLZ on Feb 22, 2023.25 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$8.6M over 180 days
-$8.6M over 90 days
below 82% of Food & Beverage
Congress
1 member bought in the last year
the lowest in Food & Beverage
Funds
under five funds report holding it
Revenue
+5.8% year over year
more than 61% of Food & Beverage
Margin
6.4% net margin
more than 69% of Food & Beverage
Buybacks
$2.4B repurchased, FY to 2025-12-31
the highest in Food & Beverage
Short interest
2.6% of the float short (float per yahoo 2026-10-26) · 3.8 days to cover · settled 2026-09-30
more than 50% of Food & Beverage
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch MDLZ
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+7.3%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MDLZ: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in MDLZ
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-08-05 · disclosed 5 days later
$1,001 - $15,000
Sold 2026-01-07 · disclosed 7 days later
$1,001 - $15,000
Sold 2025-12-18 · disclosed 28 days later
$1,001 - $15,000
Sold 2025-11-13 · disclosed 28 days later
$1,001 - $15,000
Sold 2025-11-03 · disclosed 38 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
MDLZ planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DIRK VAN DE PUT
Filed 2026-08-19
$8.4M
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Mondelez International, Inc. Pac
Cycle 2026 · $63K spent
$59.8K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mr. Van de Put
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$24.5M
$8.1M
$7.2M
+4%
+15%
2024
$22.3M
-$4.1M
$6.1M
+12%
+12%
2023
$21.0M
$49.7M
$7.1M
+33%
+11%
2022
$17.9M
$27.0M
$4.8M
+19%
+13%
2021
$16.1M
$26.8M
$5.0M
+16%
+14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.6M sold by insiders over 180 days, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $8.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
MDLZ financials
Revenue growth
+5.8%
XBRL, annual
Net margin
6.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$39.3B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM MDLZ
| FY Dec 2025 | $38.5B |
| FY Dec 2024 | $36.4B |
| FY Dec 2023 | $36.0B |
| FY Dec 2022 | $31.5B |
| FY Dec 2021 | $28.7B |
| Mar 2026 | $10.1B |
| Dec 2025 | $10.5B |
| Sep 2025 | $9.7B |
| Jun 2025 | $9.0B |
| Mar 2025 | $9.3B |
| Dec 2024 | $9.6B |
| Sep 2024 | $9.2B |
| Jun 2024 | $8.3B |
At each fiscal year end
Single quarter
Net margin, TTM
+6.6%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM MDLZ
| FY Dec 2025 | +6.4% |
| FY Dec 2024 | +12.7% |
| FY Dec 2023 | +13.8% |
| FY Dec 2022 | +8.6% |
| FY Dec 2021 | +15.0% |
| Mar 2026 | +5.6% |
| Dec 2025 | +6.3% |
| Sep 2025 | +7.6% |
| Jun 2025 | +7.1% |
| Mar 2025 | +4.3% |
| Dec 2024 | +18.2% |
| Sep 2024 | +9.3% |
| Jun 2024 | +7.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.6B
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM MDLZ
| FY Dec 2025 | $3.2B |
| FY Dec 2024 | $3.5B |
| FY Dec 2023 | $3.6B |
| FY Dec 2022 | $3.0B |
| FY Dec 2021 | $3.2B |
| Mar 2026 | $155.0M |
| Dec 2025 | $2.0B |
| Sep 2025 | $418.0M |
| Jun 2025 | $3.0M |
| Mar 2025 | $815.0M |
| Dec 2024 | $1.1B |
| Sep 2024 | $989.0M |
| Jun 2024 | $455.0M |
At each fiscal year end
Single quarter
Debt to equity
0.71x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity MDLZ
| FY Dec 2025 | 0.77x |
| FY Dec 2024 | 0.58x |
| FY Dec 2023 | 0.61x |
| FY Dec 2022 | 0.84x |
| FY Dec 2021 | 0.63x |
| Mar 2026 | 0.71x |
| Dec 2025 | 0.77x |
| Sep 2025 | 0.76x |
| Jun 2025 | 0.76x |
| Mar 2025 | 0.69x |
| Dec 2024 | 0.58x |
| Sep 2024 | 0.65x |
| Jun 2024 | 0.61x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.21x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt MDLZ
| FY Dec 2025 | 0.23x |
| FY Dec 2024 | 0.31x |
| FY Dec 2023 | 0.27x |
| FY Dec 2022 | 0.17x |
| FY Dec 2021 | 0.23x |
| Mar 2026 | 0.21x |
| Dec 2025 | 0.23x |
| Sep 2025 | 0.18x |
| Jun 2025 | 0.21x |
| Mar 2025 | 0.26x |
| Dec 2024 | 0.31x |
| Sep 2024 | 0.28x |
| Jun 2024 | 0.29x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.1%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity MDLZ
| FY Dec 2025 | +9.3% |
| FY Dec 2024 | +16.7% |
| FY Dec 2023 | +18.0% |
| FY Dec 2022 | +9.9% |
| FY Dec 2021 | +15.4% |
| Mar 2026 | +10.1% |
| Dec 2025 | +9.3% |
| Sep 2025 | +13.1% |
| Jun 2025 | +13.5% |
| Mar 2025 | +13.3% |
| Dec 2024 | +16.7% |
| Sep 2024 | +13.5% |
| Jun 2024 | +14.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.7%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets MDLZ
| FY Dec 2025 | +3.5% |
| FY Dec 2024 | +6.6% |
| FY Dec 2023 | +7.0% |
| FY Dec 2022 | +3.9% |
| FY Dec 2021 | +6.4% |
| Mar 2026 | +3.7% |
| Dec 2025 | +3.5% |
| Sep 2025 | +4.9% |
| Jun 2025 | +5.1% |
| Mar 2025 | +4.9% |
| Dec 2024 | +6.6% |
| Sep 2024 | +5.3% |
| Jun 2024 | +5.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+6.1%
operating income after a 26.4% effective tax rate, over long-term 2026-03-31 plus current 2026-03-31 plus average of 2025-03-31 and 2026-03-31 minus cash
Return on invested capital MDLZ
| FY Dec 2025 | +5.7% |
| FY Dec 2024 | +11.2% |
| FY Dec 2023 | +9.0% |
| FY Dec 2022 | +5.2% |
| FY Dec 2021 | +7.4% |
| Mar 2026 | +6.1% |
| Dec 2025 | +5.7% |
| Sep 2025 | +7.2% |
| Jun 2025 | +7.7% |
| Mar 2025 | +7.3% |
| Dec 2024 | +11.2% |
| Sep 2024 | +9.5% |
| Jun 2024 | +10.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.7%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed MDLZ
| FY Dec 2025 | +7.2% |
| FY Dec 2024 | +12.5% |
| FY Dec 2023 | +10.3% |
| FY Dec 2022 | +6.6% |
| FY Dec 2021 | +8.8% |
| Mar 2026 | +7.7% |
| Dec 2025 | +7.2% |
| Sep 2025 | +8.3% |
| Jun 2025 | +9.1% |
| Mar 2025 | +8.6% |
| Dec 2024 | +12.5% |
| Sep 2024 | +11.5% |
| Jun 2024 | +11.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
31.58x
close 2026-10-23 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing MDLZ
| FY Dec 2025 | 28.48x |
| FY Dec 2024 | 17.46x |
| FY Dec 2023 | 19.95x |
| FY Dec 2022 | 34.01x |
| FY Dec 2021 | 21.81x |
| Mar 2026 | 28.53x |
| Dec 2025 | 28.48x |
| Sep 2025 | 23.40x |
| Jun 2025 | 24.70x |
| Mar 2025 | 25.22x |
| Dec 2024 | 17.46x |
| Sep 2024 | 26.12x |
| Jun 2024 | 22.49x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value MDLZ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.1%
TTM free cash flow over market value at close 2026-10-23
FCF yield MDLZ
| FY Dec 2025 | +4.7% |
| FY Dec 2024 | +4.4% |
| FY Dec 2023 | +3.7% |
| FY Dec 2022 | +3.3% |
| FY Dec 2021 | +3.4% |
| Mar 2026 | +3.5% |
| Dec 2025 | +4.7% |
| Sep 2025 | +2.8% |
| Jun 2025 | +3.3% |
| Mar 2025 | +3.8% |
| Dec 2024 | +4.4% |
| Sep 2024 | +3.8% |
| Jun 2024 | +4.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -25%, PEG needs growth
PEG, trailing MDLZ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.23x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.95x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $38.5B | $36.4B | $36.0B | $31.5B |
| Gross profit | $10.9B | $14.3B | $13.8B | $11.3B |
| Operating income | $3.5B | $6.3B | $5.5B | $3.5B |
| Net income | $2.5B | $4.6B | $5.0B | $2.7B |
| EPS (diluted) | 1.89 | 3.42 | 3.62 | 1.96 |
| Operating cash flow | $4.5B | $4.9B | $4.7B | $3.9B |
| Long-term debt | $17.2B | $15.7B | $16.9B | $20.3B |
| Buybacks | $2.4B | $2.3B | $1.5B | $2.0B |
| Dividends paid | $2.5B | $2.3B | $2.2B | $2.0B |
SEC XBRL, fiscal years, as known on 2026-10-28
MDLZ Stock Sonar score 6/7 axes
Find similar shapesCompareMDLZ ranks highest on risk and compliance (76th percentile) and growth (61st), and lowest on institutional and government (28th), among Food & Beverage peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MDLZ filings, in plain words
Are Mondelez International insiders buying or selling MDLZ?
In the 180 days to 2026-10-28, Mondelez International insiders were net sellers, a net $8.6M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded MDLZ?
Yes. In the year to 2026-10-28, 1 House member disclosed buying MDLZ and 3 House members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-05.
Are there planned insider sales of MDLZ?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $8.4M of stock; the latest, by DIRK VAN DE PUT, was filed 2026-08-19.
Read the full summary
In the 180 days to 2026-10-28, Mondelez International insiders were net sellers of MDLZ, a net $8.6M across purchases and sales reported on Form 4 by 2 sellers. In the year to 2026-10-28, 1 member of Congress disclosed buying MDLZ and 3 members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-05. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $8.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
